Artículo

Veleiro, A.S.; Pecci, A.; Monteserín, M.C.; Baggio, R.; Garland, M.T.; Lantos, C.P.; Burton, G. "6,19-Sulfur-bridged progesterone analogues with antiimmunosuppressive activity" (2005) Journal of Medicinal Chemistry. 48(18):5675-5683
La versión final de este artículo es de uso interno de la institución.
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor

Abstract:

Sulfur-bridged pregnanes 6,19-epithioprogesterone, 21-hydroxy-6,19- epithioprogesterone, and the corresponding sulfoxides and sulfones were synthesized and tested as blockers of the immunosuppresive activity of dexamethasone in rat thymocytes. A new one-pot procedure is described for the preparation of 6,19-epithioprogesterone and related compounds by iodocyclization of a 19-sulfanylpregn-5-ene. Antiimmunosuppresive activity was evaluated by the ability of the different steroids to block dexamethasone-mediated apoptosis in thymocytes and dexamethasone-mediated inhibition of the NFκ-B transcription factor activity. DNA fragmentation and annexin V-FITC positive cells were taken as parameters of apoptosis whereas NFκ-B activity was tested by the expression of the reporter vector κB-luciferase by TNF-α in Hela cells. 21-Hydroxy-6,19-epithioprogesterone S,S-dioxide had improved activity in both parameters, while 21-hydroxy-6,19-epithioprogesterone had improved activity only in blocking dexamethasone-induced programmed cell death. © 2005 American Chemical Society.

Registro:

Documento: Artículo
Título:6,19-Sulfur-bridged progesterone analogues with antiimmunosuppressive activity
Autor:Veleiro, A.S.; Pecci, A.; Monteserín, M.C.; Baggio, R.; Garland, M.T.; Lantos, C.P.; Burton, G.
Filiación:Departamento de Química Orgánica, UMYMFOR (CONICET-FCEN), Universidad de Buenos Aires, C1428EGA Buenos Aires, Argentina
Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, C1428EGA Buenos Aires, Argentina
Departamento de Física, Facultad de Ciencias Físicas y Matemáticas, Universidad de Chile, Av. Blanco Encalada 2008, Santiago, Chile
Departamento de Física, Comisión Nacional de Energía Atómica, Av. del Libertador 8250, C1429 Buenos Aires, Argentina
Palabras clave:19 sulfanylpregn 5 ene; 21 hydroxy 6,19 epithioprogesterone; 21 hydroxy 6,19 epithioprogesterone s,s dioxide; 6,19 epithioprogesterone; dexamethasone; fluorescein isothiocyanate; immunoglobulin enhancer binding protein; lipocortin 5; progesterone derivative; sulfur derivative; tumor necrosis factor alpha; unclassified drug; animal cell; antiimmunosuppressive activity; apoptosis; article; controlled study; cyclization; drug activity; drug structure; drug synthesis; enzyme inhibition; HeLa cell; human; human cell; iodination; nonhuman; parameter; rat; structure analysis; thymocyte; Animals; Apoptosis; Cercopithecus aethiops; COS Cells; Desoxycorticosterone; Dexamethasone; Glucocorticoids; Hela Cells; Humans; Immune Tolerance; Male; Mice; Molecular Conformation; Molecular Structure; NF-kappa B; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; Stereoisomerism; Structure-Activity Relationship; Sulfides; Thymus Gland; Tumor Necrosis Factor-alpha
Año:2005
Volumen:48
Número:18
Página de inicio:5675
Página de fin:5683
DOI: http://dx.doi.org/10.1021/jm049266x
Título revista:Journal of Medicinal Chemistry
Título revista abreviado:J. Med. Chem.
ISSN:00222623
CODEN:JMCMA
CAS:dexamethasone, 50-02-2; fluorescein isothiocyanate, 25168-13-2, 27072-45-3, 3326-32-7; lipocortin 5, 111237-10-6; 21-hydroxy-6,19-epithiopregn-4-ene-3,20-dione; Desoxycorticosterone, 64-85-7; Dexamethasone, 50-02-2; Glucocorticoids; NF-kappa B; Progesterone, 57-83-0; Receptors, Progesterone; Sulfides; Tumor Necrosis Factor-alpha
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00222623_v48_n18_p5675_Veleiro

Referencias:

  • Burton, G., Lantos, C.P., Veleiro, A.S., EP 1330468, 2003; Tuckermann, J.P., Kleiman, A., McPherson, K.G., Reichardt, H.M., Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis (2005) Crit. Rev. Cl. Lab. Sci., 42, pp. 71-104
  • Weeks, C.M., Duax, W.L., Wolff, M.E., Comparison of the molecular structure of six corticosteroids (1973) J. Am. Chem. Soc., 95, pp. 2865-2868
  • Burton, G., Galigniana, M.D., De Lavallaz, S., Brachet-Cota, A.L., Sproviero, E.M., Ghini, A.A., Lantos, C.P., Damasco, M.C., Sodium retaining activity of some natural and synthetic 21-deoxysteroids (1995) Mol. Pharmacol., 47, pp. 535-543
  • Galigniana, M.D., Vicent, G.P., Piwien-Pilipuk, G., Burton, G., Lantos, C.P., Mechanism of action of the potent sodium retaining steroid 11,19-oxidoprogesterone (1998) Mol. Pharmacol., 58, pp. 58-70
  • Galigniana, M.D., Piwien Pilipuk, G., Kanelakis, K.C., Burton, G., Lantos, C.P., Molecular mechanism of activation and nuclear translocation of the mineralocorticoid receptor upon binding of pregnane steroids (2004) Mol. Cell. Endocrinol., 217, pp. 167-179
  • Piwien-Pilipuk, G., Kanelakis, K.C., Galigniana, M.D., Correlation between pregnanesteroid conformation, receptor affinity, and anti-natriuretic effect (2002) Eur. J. Pharmacol., 454, pp. 131-143
  • Vicent, G.P., Monteserín, M.C., Veleiro, A.S., Burton, G., Lantos, C.P., Galigniana, M.D., 21-Hydroxy-6, 19-oxidoprogesterone. A novel synthetic steroid with specific antiglucocorticoid properties in the rat (1997) Mol. Pharmacol., 52, pp. 749-753
  • Fernández Tresguerres, J., personal communication; Patel, F.A., Funder, J.W., Challis, J.R.G., Mechanism of cortisol/progesterone antagonism in the regulation of 15-hydroxyprostaglandin dehydrogenase activity and messenger ribonucleic acid levels in human chorion and placental trophoblast cells at term (2003) J. Clin. Endocrinol. Metab., 88, pp. 2922-2933
  • Monteserín, M.C., Veleiro, A.S., Burton, G., Photochemically induced oxidation of 6β-sulfanylpregnanes (1996) J. Chem. Res. (S), pp. 450-451
  • (1996) J. Chem. Res. (M), pp. 2601-2609
  • Nicolaou, K.C., Magolda, R.L., Sipio, W.J., Barnette, W.E., Lysenko, Z., Joullie, M.M., Phenylselenoetherification. A highly efficient cyclization process for the synthesis of O- and S-heterocycles (1980) J. Am. Chem. Soc., 102, pp. 3784-3793
  • Bednarski, J.J., Porubek, D.J., Nelson, S.D., Thiol-containing androgens as suicide substrates of aromatase (1985) J. Med. Chem., 28, pp. 775-779
  • Nitta, I., Fujimori, S., Ueno, H., The syntheses of the corticoid side chain. I. An improved method for the preparation of 17α-hydroxyprogesterone from androst-4-ene-3,17-dione (1985) Bull. Chem. Soc. Jpn., 58, pp. 978-980
  • Trost, B.M., Curran, D.P., Chemoselective oxidation of sulfides to sulfones with potassium hydrogen persulfate (1981) Tetrahedron Lett., 22, pp. 1287-1291
  • Amsterdam, A., Sasson, R., The anti-inflammatory action of glucocorticoids is mediated by cell type specific regulation of apoptosis (2002) Mol. Cell. Endocrinol., 189, pp. 1-9
  • Vayssiere, B.M., Dupont, S., Choquart, A., Petit, F., Garcia, T., Marchandeau, C., Gronemeyer, H., Resche-Rigon, M., Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo (1997) Mol. Endocrinol., 11, pp. 1245-1255
  • Wyllie, A.H., Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation (1980) Nature, 284, pp. 555-556
  • Oldenburg, N.B., Evans-Storms, J.A., Cidlowski, J.A., In vivo resistance to glucocorticoid-induced apoptosis in rat thymocytes with normal steroid receptor function in vitro (1997) Endocrinology, 138, pp. 810-818
  • Compton, M.M., Cidlowsky, J.A., Vitamin B6 and glucocorticoid action (1986) Endocr. Rev., 2, pp. 140-148
  • Fadok, V.A., Voelker, D.R., Campbell, P.A., Cohen, J.J., Bratton, D.L., Henson, P.M., Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages (1992) J. Immunol., 148, pp. 2207-2216
  • Boersma, A.W.M., Nooter, K., Oostrum, R.G., Stoter, G., Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in Chinese hamster ovary cell cultures treated with cisplatin (1996) Cytometry, 24, pp. 123-130
  • Van Der Burg, B., Van Der Saag, T., Nuclear factor-kappa-B/ steroid hormone receptor interactions as a functional basis of anti-inflammatory action of steroids in reproductive organs (1996) Mol. Hum. Reprod., 2, pp. 433-438
  • Vicent, G.P., Pecci, A., Ghini, A.A., Piwien-Pilipuk, G., Veleiro, A.S., Burton, G., Lantos, C.P., The glucocorticoid properties of the synthetic steroid pregnan-1,4-diene-11β-ol-3,20-dione (ΔHOP) are not enterely correlated with the steroid binding to the glucocorticoid receptor (1999) Mol. Cell. Endocrinol., 149, pp. 207-219
  • Pecci, A., Scholz, A., Pelster, D., Beato, M., Progestins prevent apoptosis in a rat endometrial cell line and increase the ratio of bcl-XL to bcl-XS (1997) J. Biol. Chem., 272, pp. 11791-11798
  • Hoijman, E., Rocha Viegas, L., Keller Sarmiento, M.I., Rosenstein, R.E., Pecci, A., Involvement of Bax protein in the prevention of glucocorticoid-induced thymocytes apoptosis by melatonin (2004) Endocrinology, 145, pp. 418-425
  • Viegas, L.R., Vicent, G.P., Barañao, J.L., Beato, M., Pecci, A., Steroid hormones induce bcl-X gene expression through direct activation of distal promoter P4 (2004) J. Biol. Chem., 279, pp. 9831-9839
  • Wong, T.C., Rutar, V., Homonuclear Decoupling in Heteronuclear Chemical Shift Correlation Spectroscopy. 1. Study of progesterone (1984) J. Am. Chem. Soc., 106, pp. 7380-7384
  • Sheldrick, G.M., (1997) SHELXS-97, , Program for Structure Resolution, University of Göttingen, Germany
  • Sheldrick, G.M., (1997) SHELXL-97, , Program for Structure Refinement, University of Göttingen, Germany
  • Sheldrick, G.M., (1994) SHELXTL-PC Version 5.0, , Siemens Analytical X-ray Instruments, Inc., Madison, WI
  • Kirk, D.N., Rajagopalan, M.S., Varley, M.J., An improved route to 19-hydroxypregn-4-ene-3,20-dione and synthesis of its [19-2H2] analogue (1983) J Chem. Soc., Perkin Trans. 1, pp. 2225-2227
  • Kirk, D.N., Yeoh, B.L., New syntheses of 19,21-dihydroxypregn-4-ene-3,20-dione, 21-hydroxy-19-norpregn-4-ene-3,20-dione, and 11β,19,21-trihydroxypregn-4- ene-3,20-dione (1983) J. Chem. Soc., Perkin. Trans. 1, pp. 2945-2951
  • Herrmann, M., Lorenz, H.M., Voll, R., Gruenke, M., Woith, W., Kalden, J., A rapid and simple method for the isolation of apoptotic DNA fragments (1994) Nucleic Acids Res., 22, pp. 5506-5507
  • Kastner, P., Bocquel, M., Turcotte, B., Garnier, J., Horwitz, K., Chambon, P., Gronemeyer, H., Transient expression of human and chicken progesterone receptors does not support alternative translational initiation from a single mRNA as the mechanism generating two receptors isoforms (1990) J. Biol. Chem., 265, pp. 12163-12167
  • Horwitz, K.B., Zava, D.T., Thilagia, A.K., Jensen, E.M., McGuire, W.L., Steroid receptor analyses of nine human breast cancer cell lines (1978) Cancer Res., 38, pp. 2434-2437

Citas:

---------- APA ----------
Veleiro, A.S., Pecci, A., Monteserín, M.C., Baggio, R., Garland, M.T., Lantos, C.P. & Burton, G. (2005) . 6,19-Sulfur-bridged progesterone analogues with antiimmunosuppressive activity. Journal of Medicinal Chemistry, 48(18), 5675-5683.
http://dx.doi.org/10.1021/jm049266x
---------- CHICAGO ----------
Veleiro, A.S., Pecci, A., Monteserín, M.C., Baggio, R., Garland, M.T., Lantos, C.P., et al. "6,19-Sulfur-bridged progesterone analogues with antiimmunosuppressive activity" . Journal of Medicinal Chemistry 48, no. 18 (2005) : 5675-5683.
http://dx.doi.org/10.1021/jm049266x
---------- MLA ----------
Veleiro, A.S., Pecci, A., Monteserín, M.C., Baggio, R., Garland, M.T., Lantos, C.P., et al. "6,19-Sulfur-bridged progesterone analogues with antiimmunosuppressive activity" . Journal of Medicinal Chemistry, vol. 48, no. 18, 2005, pp. 5675-5683.
http://dx.doi.org/10.1021/jm049266x
---------- VANCOUVER ----------
Veleiro, A.S., Pecci, A., Monteserín, M.C., Baggio, R., Garland, M.T., Lantos, C.P., et al. 6,19-Sulfur-bridged progesterone analogues with antiimmunosuppressive activity. J. Med. Chem. 2005;48(18):5675-5683.
http://dx.doi.org/10.1021/jm049266x